Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

2123

Actual shortage: 50 (2%)
Anticipated shortage: 9 (0%)
Avoided shortage: 19 (1%)
Resolved: 2045 (96%)

Discontinuation Reports

101

To be discontinued: 1 (1%)
Discontinued: 98 (97%)
Reversed: 2 (2%)

Late reports

444 (20%)

Overdue reports

38 (63%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ ADAPALENE / BENZOYL PEROXIDE 2.5% 0.1% GEL Resolved 2023-05-01 2023-05-25 191366
SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE 2.5% 0.3% GEL Resolved 2024-09-16 2024-11-19 237724
SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE 2.5% 0.3% GEL Resolved 2024-02-05 2024-03-12 218447
SANDOZ ALENDRONATE 70MG TABLET Resolved 2024-11-18 2025-01-13 243330
SANDOZ ALENDRONATE 70MG TABLET Resolved 2023-04-04 2023-05-25 188633
SANDOZ ALENDRONATE 70MG TABLET Resolved 2022-10-12 2022-12-28 171540
SANDOZ ALENDRONATE 70MG TABLET Resolved 2017-11-13 2017-11-27 29082
SANDOZ ALENDRONATE/CHOLECALCIFEROL 70MG 5600UNIT TABLET Resolved 2017-11-13 2018-07-03 29085
SANDOZ ALENDRONATE/CHOLECALCIFEROL 70MG 5600UNIT TABLET Resolved 2020-01-22 2020-02-11 103988
SANDOZ ALFACALCIDOL 0.25MCG CAPSULE Resolved 2025-01-20 2025-02-11 248121
SANDOZ ALFACALCIDOL 1MCG CAPSULE Resolved 2025-01-21 2025-02-11 248199
SANDOZ ALFACALCIDOL 1MCG CAPSULE Resolved 2024-09-09 2025-01-18 237133
SANDOZ ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-16 2024-05-14 225209
SANDOZ ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-09-16 2025-01-14 237728
SANDOZ ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-16 2023-01-19 174953
SANDOZ ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-05 2022-05-10 157959
SANDOZ ALMOTRIPTAN 12.5MG TABLET Resolved 2017-07-05 2017-10-25 14659
SANDOZ ALMOTRIPTAN 12.5MG TABLET Resolved 2019-02-04 2019-03-13 74593
SANDOZ AMBRISENTAN TABLETS 5MG TABLET Resolved 2024-01-30 2024-04-24 217887
SANDOZ AMBRISENTAN TABLETS 10MG TABLET Resolved 2024-02-05 2024-04-24 218454

Showing 521 to 540 of 2123

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Discontinued 2020-06-22 2020-06-22 118553

Showing 1 to 20 of 101